Therapeutic effects of Schisandra chinensis on the hyperprolactinemia in rat

Hong,So-Hye; Li,Mei; Jeung,Eui-Bae; Lee,Geun-Shik; Hong,Eui-Ju; Choi,Young-Whan; An,Beum-Soo

doi:10.3892/ijo.2017.3881

Therapeutic effects of Schisandra chinensis on the hyperprolactinemia in rat

Authors:
- So-Hye Hong
- Mei Li
- Eui-Bae Jeung
- Geun-Shik Lee
- Eui-Ju Hong
- Young-Whan Choi
- Beum-Soo An
View Affiliations

Affiliations: Department of Biomaterials Science, College of Natural Resources and Life Science, Pusan National University, Miryang‑si, Gyeongsangnam‑do, Republic of Korea, Department of Horticultural Bioscience, College of Natural Resources and Life Science, Pusan National University, Miryang-si, Gyeongsangnam‑do, Republic of Korea, Laboratory of Veterinary Biochemistry and Molecular Biology, College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk, Republic of Korea, College of Veterinary Medicine and Institute of Veterinary Science, Kangwon National University, Chuncheon, Gangwon 200‑701, Republic of Korea, Laboratory of Biochemistry and Molecular Biology, College of Veterinary Medicine, Chungnam National University, Daejeon, Gangwon, Republic of Korea
Published online on: February 17, 2017 https://doi.org/10.3892/ijo.2017.3881
Pages: 1448-1454

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Prolactin (PRL) is secreted from the pituitary gland in response to eating, mating, and ovulation. Increased serum concentration of PRL during pregnancy contributes to enlargement of the mammary glands of the breasts and prepares for production of milk. However, high PRL levels derived from prolactinoma and hyperprolactinemia induce physiological disorders such as infertility and early menopause. Natural compounds isolated from S. chinensis have been known to possess anti-oxidative, anti-inflammatory and anti-diabetic effects. In the present study, we examined the therapeutic effect of S. chinensis and its single compounds on hyperprolactinemia in the pituitary gland. In rat pituitary cells, PRL expression levels were examined using real-time PCR and western blot assay. Crude S. chinensis extract and its single compound, gomisin N, reduced mRNA and protein levels of PRL in GH3 cells. In addition, cell proliferation and PRL target gene expression in cells were modulated by S. chinensis. Similar to the in vitro experiments, crude S. chinensis extract and gomisin N reduced PRL levels in the pituitary and serum of immature female rats. These results show that S. chinensis and its single compound, gomisin N, are regulators of PRL production and may be candidates for treatment of hyperprolactinemia and prolactinoma.

View Figures

View References

1	Hong GK, Payne SC and Jane JA Jr: Anatomy, physiology, and laboratory evaluation of the pituitary gland. Otolaryngol Clin North Am. 49:21–32. 2016. View Article : Google Scholar
2	Amar AP and Weiss MH: Pituitary anatomy and physiology. Neurosurg Clin N Am. 14:11–23. v2003. View Article : Google Scholar : PubMed/NCBI
3	Blackwell RE, Rodgers-Neame NT, Bradley EL Jr and Asch RH: Regulation of human prolactin secretion by gonadotropin-releasing hormone in vitro. Fertil Steril. 46:26–31. 1986. View Article : Google Scholar : PubMed/NCBI
4	Freeman ME, Kanyicska B, Lerant A and Nagy G: Prolactin: Structure, function, and regulation of secretion. Physiol Rev. 80:1523–1631. 2000.PubMed/NCBI
5	Ben-Jonathan N and Hnasko R: Dopamine as a prolactin (PRL) inhibitor. Endocr Rev. 22:724–763. 2001. View Article : Google Scholar : PubMed/NCBI
6	Rillema JA: Mechanism of prolactin action. Fed Proc. 39:2593–2598. 1980.PubMed/NCBI
7	McMurray RW: Estrogen, prolactin, and autoimmunity: Actions and interactions. Int Immunopharmacol. 1:995–1008. 2001. View Article : Google Scholar : PubMed/NCBI
8	Capozzi A, Scambia G, Pontecorvi A and Lello S: Hyperprolactinemia: Pathophysiology and therapeutic approach. Gynecol Endocrinol. 31:506–510. 2015. View Article : Google Scholar : PubMed/NCBI
9	Glezer A and Bronstein MD: Prolactinomas. Endocrinol Metab Clin North Am. 44:71–78. 2015. View Article : Google Scholar : PubMed/NCBI
10	Panossian A and Wikman G: Pharmacology of Schisandra chinensis Bail: An overview of Russian research and uses in medicine. J Ethnopharmacol. 118:183–212. 2008. View Article : Google Scholar : PubMed/NCBI
11	Hancke JL, Burgos RA and Ahumada F: Schisandra chinensis (Turcz) Baill. Fitoterapia. 70:451–471. 1999. View Article : Google Scholar
12	Chang HM and But P: Pharmacology and applications of Chinese Materia Edica Volume 1. World Scientific; Singapore: pp. 199–209. 1986, View Article : Google Scholar
13	Bao T-T, Tu G-F, Liu G-T, Sun R-H and Song Z-Y: A comparison of the pharmacological actions of seven constituents isolated from fructus schizadrae (author's transl). Yao Xue Xue Bao. 14:1–7. 1979.In Chinese.
14	Cowie AT: Physiological actions of prolactin. Proc R Soc Med. 66:861–862. 1973.PubMed/NCBI
15	Mancini T, Casanueva FF and Giustina A: Hyperprolactinemia and prolactinomas. Endocrinol Metab Clin North Am. 37:67–99. viii2008. View Article : Google Scholar : PubMed/NCBI
16	Schwärzler P, Untergasser G, Hermann M, Dirnhofer S, Abendstein B and Berger P: Prolactin gene expression and prolactin protein in premenopausal and postmenopausal human ovaries. Fertil Steril. 68:696–701. 1997. View Article : Google Scholar : PubMed/NCBI
17	Ufearo CS and Orisakwe OE: Restoration of normal sperm characteristics in hypoprolactinemic infertile men treated with metoclopramide and exogenous human prolactin. Clin Pharmacol Ther. 58:354–359. 1995. View Article : Google Scholar : PubMed/NCBI
18	Bronstein MD: Potential for long-term remission of microprolactinoma after withdrawal of dopamine-agonist therapy. Nat Clin Pract Endocrinol Metab. 2:130–131. 2006. View Article : Google Scholar : PubMed/NCBI
19	Auriemma RS, Pivonello R, Ferreri L, Priscitelli P and Colao A: Cabergoline use for pituitary tumors and valvular disorders. Endocrinol Metab Clin North Am. 44:89–97. 2015. View Article : Google Scholar : PubMed/NCBI
20	Murphy LL and Lee TJ: Ginseng, sex behavior, and nitric oxide. Ann N Y Acad Sci. 962:372–377. 2002. View Article : Google Scholar : PubMed/NCBI
21	Yeh KY, Pu HF, Kaphle K, Lin SF, Wu LS, Lin JH and Tsai YF: Ginkgo biloba extract enhances male copulatory behavior and reduces serum prolactin levels in rats. Horm Behav. 53:225–231. 2008. View Article : Google Scholar
22	Lu JC, Piazza TM and Schuler LA: Proteasomes mediate prolactin-induced receptor down-regulation and fragment generation in breast cancer cells. J Biol Chem. 280:33909–33916. 2005. View Article : Google Scholar : PubMed/NCBI
23	Zinger M, McFarland M and Ben-Jonathan N: Prolactin expression and secretion by human breast glandular and adipose tissue explants. J Clin Endocrinol Metab. 88:689–696. 2003. View Article : Google Scholar : PubMed/NCBI
24	Chen CL and Meites J: Effects of estrogen and progesterone on serum and pituitary prolactin levels in ovariectomized rats. Endocrinology. 86:503–505. 1970. View Article : Google Scholar : PubMed/NCBI
25	Kang EJ, Hong SH, Lee JE, Kim SC, Yang HS, Yi PI, Lee SM and An BS: Pregnenolone sulfate regulates prolactin production in the rat pituitary. J Endocrinol. 230:339–346. 2016. View Article : Google Scholar : PubMed/NCBI
26	Yim SY, Lee YJ, Lee YK, Jung SE, Kim JH, Kim HJ, Son BG, Park YH, Lee YG, Choi YW, et al: Gomisin N isolated from Schisandra chinensis significantly induces anti-proliferative and pro-apoptotic effects in hepatic carcinoma. Mol Med Rep. 2:725–732. 2009.PubMed/NCBI
27	Kim JH, Choi YW, Park C, Jin CY, Lee YJ, Park DJ, Kim SG, Kim GY, Choi IW, Hwang WD, et al: Apoptosis induction of human leukemia U937 cells by gomisin N, a dibenzocyclooctadiene lignan, isolated from Schizandra chinensis Baill. Food Chem Toxicol. 48:807–813. 2010. View Article : Google Scholar
28	Casarin E, Dall'Acqua S, Smejkal K, Slapetova T, Innocenti G and Carrara M: Molecular mechanisms of antiproliferative effects induced by Schisandra-derived dienzocyclooctadiene lignin ()-deoxychisandrin and (-)-gomisin N in human tumor cell lines. Fitoterapia. 98:241–247. 2014. View Article : Google Scholar : PubMed/NCBI